An intravitreal injection is the most common procedure performed in ophthalmology.
In the U.S., intravitreal injections are in most cases an office-based procedure. As I have stated many times, the office is a critically important source of revenue for the ophthalmologist, and office-based intravitreal injections can be a meaningful source of income for the practice that provides them. The most common indications are wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema and retinal vein occlusion. The accompanying cover story focuses on wet AMD.
According to the